Novocure | search
Click here to view Novocure news from 60+ newspapers.
Bookmark or Share- Novocure | cancer therapy: Tumor Treating Fields (TTFields)Novocure (NASDAQ: NVCR) is an oncology company pioneering a novel therapy for solid tumors called Tumor Treating Fields, or TTFields.
- FDA Approves Novocure’s Optune Lua® for the Treatment of Metastatic Non ...“Novocure is committed to extending survival in some of the most aggressive and difficult to treat cancers. The approval of Optune Lua brings a new and urgently needed option for people with metastatic NSCLC who have progressed while on or after platinum-based chemotherapy,” said Asaf Danziger, CEO, Novocure.
- news and media center - NovocureStay updated with the latest Novocure news, press releases and company stories. We strive to extend survival in some of the most aggressive forms of cancer.
- Novocure Announces Positive Topline Results from Phase 3 PANOVA-3 ...Novocure plans to file for regulatory approval of TTFields in unresectable, locally advanced pancreatic adenocarcinoma based on PANOVA-3 and plans to submit the PANOVA-3 results for presentation at an upcoming medical congress.
- Novocure to Participate in Upcoming Investor ConferencesNovocure is a global oncology company working to extend survival in some of the most aggressive forms of cancer through the development and commercialization of its innovative therapy, Tumor Treating Fields.
More
